ArticleDiscover oncology2023

ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance.

Chao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.